836 results about "Biomolecule" patented technology

Systems and methods are provided for stabilization of cells and retention of biomolecules therein for further analysis. Block copolymers are inserted into membranes of biological particles, cell membranes or organelles (e.g., organelle membranes) and polymerized to form an intra-biological particle (e.g., intracellular) polymer network.

A platform for characterizing biomolecules, biological tissue sections, viruses, or other particles of interest in a non-invasive, high-throughput, cost-effective, and label-free manner. The platform includes a merged set of imaging modalities including and capable of interferometric microscopy and wide-field or confocal microscopy (such as, for example, a wide-field super-resolution surface enhanced Raman spectroscopy, SERS), although some aspects may be employed with data sets only received from wide-field or confocal microscopy. Related devices, systems, methods, techniques, and variations to the same are also provided.

The present disclosure relates to compositions and methods for reversible fixation of biological samples using fixation reagents that form bis-carbamate crosslinks between amine-bearing moieties in biomolecules.

The invention discloses a non-coding RNA (Ribonucleic Acid) and disease association prediction method based on a graph neural network, and belongs to a biomolecule association prediction technology in the field of biological information. The invention breaks through the limitation of a single task of a conventional method, and provides a novel multi-task learning framework based on task migration. Potential LDA, MDA and LMI can be deduced by effectively utilizing the known complex relationship among lncRNA, miRNA and diseases. A plurality of graph structures are constructed, including a bipartite graph, a feature structure graph and a meta-path graph. The synergistic effect of the multi-graph structure significantly enriches the context information of the nodes, and effectively improves the prediction accuracy of the model. Pairwise attribute learning is introduced and is used for capturing the direct relationship among lncRNA, miRNA and diseases. According to the method, the prediction performance is improved, overfitting is effectively reduced, and the robust generalization ability of the model is ensured.

Strategies, systems, methods, reagents, and kits for phage-assisted continuous evolution are provided herein. These include strategies, systems, methods, reagents, and kits allowing for stringency modulation to evolve weakly active or inactive biomolecule variants, negative selection of undesired properties, and / or positive selection of desired properties.

The invention discloses a lipid compound capable of being used for gene delivery, a preparation method of the lipid compound and application of the lipid compound in gene delivery. Also disclosed herein is a lipid nanoparticle comprising the lipid compound, a gene delivery composition comprising the lipid compound or the lipid nanoparticle. The lipid compounds, lipid nanoparticles and delivery systems herein enable efficient complexation, protection, intracellular and targeted delivery and release of biomolecules, such as oligonucleotides and nucleic acids, in vitro and in vivo tissues and organs.

The invention provides a wide pH applicable multi-biomolecule detection MOF probe, a preparation method, a detection method and application, the probe is an MIL-53 (Fe) (at) AA (at) EZ probe, and comprises a metal organic framework MIL-53 (Fe), amino acid and enzyme; the preparation method comprises the following steps: weighing terephthalic acid and ferric chloride hexahydrate, adding into N, N-dimethylformamide, mixing and stirring, pouring the mixed solution into a stainless steel autoclave, heating and reacting, naturally cooling to room temperature, centrifugally separating a product, and washing with N, N-dimethylformamide and absolute ethyl alcohol to obtain the metal organic framework MIL-53 (Fe). The preparation method comprises the following steps: mixing a metal organic framework MIL-53 (Fe) with an amino acid solution, and carrying out ultrasonic treatment and stirring to obtain an MIL-53 (Fe) coated AA solution; the method comprises the following steps: dissolving enzyme in an MIL-53 (Fe) (at) AA solution, uniformly mixing, stirring, centrifugally separating a product, taking precipitate, and drying in vacuum to obtain the MIL-53 (Fe) (at) AA (at) EZ probe. The pH application range is wide, one-step detection can be achieved, and the method has the advantages of being rapid in reaction, high in sensitivity, low in detection limit and easy and convenient to operate.

The embodiment of the invention discloses a terahertz virus spectrum classification method and system based on transfer learning, and the method comprises the steps: obtaining a source domain terahertz spectrum data set containing various biomolecule hydrogen bond vibrations, and obtaining an initial feature extraction model; extracting a hydrogen bond vibration characteristic mode in a preset frequency band range, and taking a characteristic center of the hydrogen bond vibration characteristic mode as a cross-domain bridging characteristic; obtaining target sample data, wherein the sample data is a small sample data set; converting the similarity between the feature center and a target sample spectrum peak into a dynamic weight of a migration loss function, and performing layer-by-layer fine adjustment on the initial feature extraction model network to obtain a virus classification model; the fine tuning process comprises the following steps: adjusting a weight factor in real time according to the spectrum peak offset of the current batch of samples; inputting the terahertz spectrum data of the to-be-detected virus into the virus classification model to obtain a classification result of the to-be-detected virus. According to the application, the accuracy, robustness and industrial applicability of terahertz virus detection are remarkably improved.

This invention is related to the field of biosensors. In particular, devices and methods are described which enable the quantification of biomolecules by virtue of particle speed driven by induced-charge electrophoresis. For example, a range of biomolecules can be simultaneously detected in a highly sensitive manner from a library (e.g., combination) of active particles having different shapes or fluorescent signatures. Such biomolecules are related to conditions including, but not limited to, cancer biomarkers, viral infection biomarkers, toxins, pesticides, and small molecule drugs.

The invention provides a nucleic acid aptamer and a screening method thereof, the aptamer is of an oligonucleotide DNA structure, the nucleotide sequence of the nucleic acid aptamer is the nucleotide sequence of any DNA fragment as shown in SEQ ID NO: 1-9, and the nucleic acid aptamer can specifically target cardiac muscle cells (CMs). According to the invention, a new strategy can be provided for clinical treatment of cardiovascular diseases, and meanwhile, bioactive molecules such as microRNA (miRNA), small interfering RNA (small interfering RNA, siRNA), lipidosome, microspheres, microcapsules and the like can be carried to be used as an intracellular drug delivery tool.

Disclosed herein are systems and methods for direct classification of biological datasets. The datasets may include raw mass spectrometry data. Some aspects include training a classifier for direct classification of raw data, and some aspects include applying the classifier.

Disclosed herein are a peptoid compound and a peptoid conjugate such as a peptoid-lipid conjugate, and preparation methods therefor and the use thereof in a small molecule drug and nucleic acid delivery. Further disclosed herein are a lipid particle containing the peptoid-lipid conjugate, such as a liposome and a lipid nanoparticle, and a small molecule drug and / or a nucleic acid delivery composition containing the peptoid-lipid conjugate or the lipid particle. The peptoid-lipid conjugate, lipid particle, and small molecule drug and / or nucleic acid delivery composition that can be used for the small molecule drug and nucleic acid delivery of the present invention enable highly efficient compounding, protection, intracellular and targeted delivery and release of the small molecule drug and biomolecules, such as nucleic acids, in tissues and organs both in vitro and in vivo.

The invention provides a cation exchange membrane chromatography medium and a preparation method and application thereof, the cation exchange membrane chromatography medium comprises a homo-porous membrane, polydopamine is loaded on two side surfaces and in a pore structure of the homo-porous membrane, and a cation exchange functional ligand is grafted on the polydopamine; a homogeneous pore membrane is selected as a matrix membrane, polydopamine is loaded on the surface and in an internal pore structure of the homogeneous pore membrane, and then a cation exchange functional ligand is further grafted, so that the surface of a chromatography medium of the obtained cation exchange membrane has relatively strong negative charges, and biomolecules with positive charges can be effectively adsorbed, thereby being separated from biomolecules with negative charges; meanwhile, the membrane is relatively low in transmembrane pressure and relatively high in separation degree, also has the characteristics of high permeability and high selectivity, and is suitable for being applied to separation and purification of biological drug macromolecules.

The invention provides a defect early warning method and device for multi-source heterogeneous data fusion of power equipment, and the method comprises the steps: collecting biological data, quantum data and operation data of the power equipment; performing biomolecular diagnosis on the biological data to obtain biological characteristic information; laying a quantum cobweb based on the quantum data to obtain quantum feature information; performing feature fusion on the biological feature information and the quantum feature information to obtain feature fusion information; performing space-time coding conversion on the feature fusion information and extracting bionic features to obtain space-time feature information; generating a space-time pulse characteristic flow based on the space-time characteristic information; constructing a holographic decision field through the space-time pulse characteristic flow; performing risk deduction by using the holographic decision field to generate a defect evolution cloud picture; and generating defect early warning information based on the defect evolution cloud atlas and the operation data. According to the method, potential defects of the equipment can be accurately found in advance, the equipment failure rate is reduced, and the reliability and stability of the power system are improved.

A biomolecule analysis method of the present disclosure includes: preparing a biomolecule analysis device including a thin film, a first liquid tank and a second liquid tank separated by the thin film, a first electrode disposed in the first liquid tank, and a second electrode disposed in the second liquid tank; and forming a nanopore in the thin film by applying a first voltage between the first electrode and the second electrode in a state where a nanopore forming solution is enclosed in the first liquid tank and the second liquid tank, wherein the nanopore forming solution contains ammonium ions and sulfate ions.

The present disclosure relates to a method and device for unmixing fluorescent signals based on a joint histogram. The method and device may be configured to obtain a plurality of images of a plurality of fluorescent materials marked in different biomolecules and to unmix the signals of the fluorescent materials based on at least one joint histogram index defined between the images of each of pairs each including two or more of the obtained images. According to the present disclosure, the joint histogram index may include at least one of Kullback-Leibler divergence, cross-entropy, or Rand-index.

The invention discloses a zinc transition metal complex and preparation and application thereof in fluorescence recognition of biomolecules, and relates to the technical field of metal organic framework materials, the chemical formula of the zinc transition metal complex is [Zn2 (L) 2 (bpe) (H2O) 2] n, and 3, 5-bis (3-carboxylic acid phenyl)-1, 2, 4-triazole, 1, 2, 4-triazole, 1, 3, 4-triazole, 1, 3, 4-triazole, 1, 3, 4-triazole, 1, 3, 4-triazole, 1, 3, 4-triazole, 1, 3, 4-triazole, 1, 3, 4-triazole, 1, 3, 4-triazole The complex material is prepared by co-dissolving 2, 2-bis (4-pyridyl) ethylene, Zn (NO3) 3.6 H2O and N, N-dimethylformamide in an aqueous solution, has excellent fluorescence performance, has the capability of specifically identifying ascorbic acid in various biomolecules, and also has relatively good anti-interference performance, excellent circularity and strong stability, and can be widely applied to the field of biochemistry, biochemistry, biochemistry, biochemistry, biochemistry, biochemistry, biochemistry, biochemistry, biochemistry, biochemistry, biochemistry, biochemistry, biochemistry, biochemistry, biochemistry and biochemistry. The method can be used for detecting ascorbic acid in water and beverages.

Described herein are methods for screening for a disease state. The method may include obtaining multiple data sets and identifying the disease state based on a combination of the data sets. The data sets may include biomolecule measurements obtained by multiple methods, such as through the use of particles and reference biomolecules.

The application discloses a defluorination agent for fluorine-containing wastewater treatment and a preparation method thereof. The defluorination agent is prepared from chitosan as a biomolecular skeleton and magnesium salt, titanium salt, zirconium salt, aluminum salt, iron salt, rare earth material and organic material as blending raw materials. The mass ratio of the magnesium salt, the titanium salt, the zirconium salt, the aluminum salt, the iron salt, the rare earth material, the organic material and the chitosan is 1-30:1-30:2-20:2-10:2-10:20-50:2-10:1-10. The defluorination agent is prepared from the magnesium salt, the titanium salt, the zirconium salt and the organic material in addition to the existing composite defluorination agent, and has the characteristics of good stability, wide application range and large-scale application.

Provided herein are systems and methods for detecting and analyzing biomolecules. In particular, provided herein are sensor systems employing an enzyme comprising an allosteric site that interacts with an inhibitor to determine the presence, absence, or amount of one or more target analytes in a sample. In some embodiments, the allosteric sites comprise graft epitopes corresponding to one or more analytes of interest.

The invention belongs to the technical field of biomolecular interaction detection, and particularly relates to a method for synergistically analyzing a molecular interaction state based on multimodal optical parameters of a rare earth up-conversion nano material. The method comprises the following steps: S1, providing a ligand coated rare earth up-conversion nano material UCNPs probe; s2, enabling the rare earth up-conversion nano material UCNPs probe to be in contact with a solution sample to be detected; s3, exciting the rare earth up-conversion nano material UCNPs probe by using near-infrared pulse laser, and collecting the following optical parameters: luminous intensity change, molecular layer thickness / mass change delta D, luminous life change delta tau and emission peak displacement delta lambda; and S4, based on at least two of the parameters, cooperatively analyzing and judging the interaction state of the ligand on the surface of the probe and the molecules in the solution sample to be detected. The molecular interaction state is synergistically analyzed based on changes of multiple optical parameters, and the technical problem that an existing molecular interaction analysis technology cannot be applied to complex biological samples (serum and cell lysis buffer) is solved.

The invention discloses an aza-BODIPY biomedical phototherapy agent taking oxajulolidine as a donor and a preparation method thereof, and relates to a medical phototherapy agent for treating brain glioma and a preparation method thereof, and the prepared compound is prepared by introducing an oxajulolidine fragment with electron donating property into a key position of an aza-BODIPY skeleton, so that the aza-BODIPY biomedical phototherapy agent is obtained. The donor-acceptor type molecular near-infrared phototherapy agent with a new structure is constructed, has good near-infrared absorption and emission performance and excellent stability, and shows a remarkable effect in the field of cancer photodynamic (PDT)-photothermal (PTT) synergistic treatment. The structural categories of the near-infrared aza-BODIPY biomolecules are enriched, and a new molecular platform is provided for expansion and application of the near-infrared aza-BODIPY biomolecules in the fields of biological imaging, tumor diagnosis and treatment, functional materials and the like.

A polyelectrolyte-surfactant complex, a method of removing a toxic substance from contaminated soil or contaminated groundwater using a polyelectrolyte-surfactant complex and a method of making a polyelectrolyte-surfactant complex. The polyelectrolyte-surfactant complex is made from a complexated recombinant intrinsically disordered protein that has been electrostatically conjugated to an anionic surfactant to provide enhanced liquid-liquid phase separation properties.

Embodiments of the present disclosure relate to a composition that comprises a recombinant plasmid (RP) with a sequence of nucleic acids. The sequence comprise a start region, an end region and an insert positioned between the start region and the end region. The insert encodes for a sequence of micro interfering ribonucleic acid (miRNA) that may be complimentary to a sequence of target messenger RNA (mRNA) that encodes for translation of a target biomolecule. The miRNA can cause the target mRNA to be degraded or inactivated, thereby causing a decrease in bioavailability of the target biomolecule because it is degraded or inactivated by the miRNA, thereby decreasing the bioavailability of the target biomolecule. In some embodiments of the present disclosure, the target biomolecule is an immune checkpoint protein.

Insects with elevated levels of protein, chitin, elements, amino acids, vitamins, and / or sterols are disclosed. The insects have elevated levels due to a diet that includes mushroom biomass. The mushroom biomass includes any one or more of the mushroom fruitbody, the stem, and the mycelium. The enriched insects with biomolecules from mushroom biomass can be used as they are or as supplements to increase the levels of biomolecules in humans or other animals that may ingest the insects or a modified form of the insect.

The present invention provides methods and devices for detecting and quantifying multiple biomolecules at single-molecule level using an integrated droplet microfluidic system. In one embodiment, the present invention provides real-time and digital measurement of multiple biomolecules in a sample, thereby quantifying multiple biomolecules in an absolute and simultaneous manner. In one embodiment, the present invention provides a diagnostic method for a disease, comprising real-time and digital measurement of multiple biomolecules in a sample using the method or device described herein.

The present disclosure provides a method for the chemoselective modification of a target molecule. The subject methods comprise contacting a target molecule comprising a thiol moiety with a biomolecule comprising a reactive moiety, wherein the reactive moiety is produced by reacting a biomolecule comprising a phenol moiety or catechol with an enzyme capable of oxidizing the phenol moiety or the catechol moiety. The contacting is performed under conditions sufficient to conjugate the target molecule to the biomolecule, thereby producing a modified target molecule. The present disclosure provides compositions comprising a subject target molecule comprising a thiol moiety and a biomolecule comprising a phenol moiety or a catechol moiety. The present disclosure provides kits for performing the subject methods. The disclosure also provides modified target molecules and methods of using the same.

The invention discloses a method for predicting multi-type association in a miRNA-LncRNA-disease network through a simplified input strategy, and relates to the technical field of biomolecular association prediction, and the method comprises the following steps: data acquisition and preprocessing, heterogeneous network construction, deep feature extraction, feature fusion, multi-task joint prediction and result output. Innovation and breakthrough of correlation prediction of multiple types of biomolecules are achieved by simplifying an input strategy and a depth feature fusion mechanism, a verified binary correlation matrix is adopted to replace a traditional similarity network, redundant calculation noise can be effectively avoided, and the correlation prediction of multiple types of biomolecules is achieved by stacking a depth matrix decomposition module. Low-dimensional features are gradually extracted by adopting an encoder-decoder cascade structure, known associated signals can be enhanced, false negative interference can be inhibited, and by introducing a dynamic weighted feature fusion and multi-task joint prediction framework, the collaborative reasoning capability of three types of associations can be synchronously optimized, and the data collection complexity is remarkably reduced.

Provided herein are methods for multiplexed in situ analysis of biomolecules in a tissue. In particular, provided herein are methods for multiplexed single-cell in situ protein and nucleic acid profiling in fixed or fresh tissues, that allows the investigation of the different cell compositions and their spatial organizations in intact tissues through consecutive cycles of probe hybridization, fluorescence imaging, and signal removal.

The embodiment of the present application provides a nucleic acid processing method, and relates to the technical field of biomolecule detection. The nucleic acid processing method comprises the following steps: in the extraction process of the nucleic acid, the magnetic beads can be stirred, the magnetic beads can be scattered in liquid vortex, the magnetic beads can be suspended under the action of a magnetic field, and the magnetic beads cannot fall into other channels after moving away from the magnetic field, so that the loss of the magnetic beads is reduced, the nucleic acid extraction can be completed, the accuracy of inspection is improved, high-precision nucleic acid extraction is realized, and high-precision nucleic acid amplification can also be realized.